aDivision of Metabolism, Digestion and Reproduction, Imperial College London, London, UK bDepartment of Diabetes and Endocrinology, Imperial College Healthcare NHS Trust, London, UK cDepartment of ...

zObesity and Comorbities Research Center, Laboratory of Investigation in Metabolism and Diabetes/Gastrocentro, Universidade de Campinas, Campinas, São Paulo, Brazil aaDepartment of Medicine and ...

Acyclovir is a generic prescription drug that’s used to treat certain viral infections. Acyclovir comes as an oral tablet. Acyclovir oral tablet is only available as a generic drug. It doesn’t ...

Rivaroxaban (2.5 mg twice daily) combined with low-dose aspirin (81 mg daily) is effective to prevent major adverse cardiovascular events and major adverse limb events in patients with PAD who are not ...

Forecasters say Sunday will bring sunny skies and mild temperatures across western Washington, with highs in the low to mid-70s just in time for Father's Day.

Personal and small business cards issued by US Bank are currently not available on CNBC Select and links have been redirected to our credit card marketplace where you can review offers from ...

What are the best games on PlayStation 5? Now that supply issues are over, Sony’s latest console is flying off shelves, while its library of games rapidly fills up. New and old PS5 owners will ...

It will certainly feel like the start of summer this weekend with highs in the mid 90s. The heat index will range from 100 to 104. Pace yourself and try to stay cool! More of the same is expected ...

Mounjaro’s typical starting dosage is 2.5 milligrams (mg) once per week for 4 weeks, after which your doctor may increase the dose to 5 mg per week if needed to manage blood sugar levels.

Lilly, meanwhile, has been selling its GLP-1 agonist Trulicity (dulaglutide) in China since 2019, while its dual GLP-1/GIP agonist tirzepatide was approved for diabetes in May and for obesity just ...

supporting products like GLP-1 agonist Trulicity (dulaglutide) and dual GIP/GLP-1 agonist Mounjaro (tirzepatide) for diabetes, as well as newly-approved obesity therapy Zepbound (tirzepatide).

Rachel Burden and Rick Edwards with the new look 5 Live Breakfast, featuring unique stories from across the UK, explaining the details behind the headlines, and the biggest news and sport.